Pelabresib (CPI-0610) monotherapy in patients with myelofibrosis - Update of clinical and translational data from the ongoing MANIFEST trial Meeting Abstract
| Authors: | Kremyanskaya, M.; Mascarenhas, J.; Palandri, F.; Vannucchi, A.; Verstovsek, S.; Harrison, C. N.; Bose, P.; Schiller, G. J.; Rampal, R.; Drummond, M. W.; Gupta, V.; Patriarca, A.; Granacher, N.; Scandura, J.; Prejzner, W.; Teichmann, L. L.; Curto-Garcia, N.; Hoffman, R.; Colak, G.; Ren, Z.; Bobba, S.; Cui, J.; Efuni, S.; Talpaz, M. |
| Abstract Title: | Pelabresib (CPI-0610) monotherapy in patients with myelofibrosis - Update of clinical and translational data from the ongoing MANIFEST trial |
| Meeting Title: | 63rd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000736398800139 |
| DOI: | 10.1182/blood-2021-150172 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 141 -- Source: Wos |
